Heatbud logo
Business Visit zone home page
Open Zone
< Previous Post
> Next Post
Create a Post
Create a Zone
Login to favorite zones.
  • market research
  • business
  • business
  • business
  • Market ResearchNest
  • Business
  • Market Research Reports
  • Trendy Women Tops That Will Help You To Improve
  • MarketResearch
  • eMarketOrg.com
  • Zion Market Research
  • Market Research Report
  • AlgoroReports
  • Market Research Reports and Forecast
  • Singing Bowls
  • My Zone
  • Car Accessories
  • Yada Yada Yada
  • Travel
  • Market Research Future
Join the Social Blogging revolution!
Rapid Growth Of Biological Drugs Market - Analysis, Growth, Trends and Forecast 2014 - 2020
Share Blog Post by URL Like Heatbud on Facebook
UNIQUE VIEWS   +   UP VOTES Vote Up   -   DOWN VOTES Vote Down   +   COMMENTS Comments   =   HEAT INDEX What is Heat Index?

About Biological Drugs Market


Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Biological drugs include therapeutic proteins, monoclonal antibody (mAb) and vaccines. The biological drugs market is growing due to the increasing prevalence of chronic diseases and the demand for biological drugs is growing due to the increase in the global geriatric population. Moreover, various government associations are also supporting in growth of biological drugs market. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market.


On the other hand, high cost of biologic drugs and patent expiry of blockbuster drugs impede the growth of the biological drugs market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one of the key restraints of the biological drugs market.


Get Sample Copy of this report @



The report provides in-depth analysis and estimation of the biological drugs market from 2014 to 2020, considering 2013 as the base year for calculation. Additionally, data pertaining to current market dynamics including market drivers, restraints, trends and recent developments has been provided in the biological drugs market report. The global biological drugs market is categorized based on therapeutic protein, monoclonal antibody (mAb), vaccine and geography. The therapeutic protein segmentation is further sub-segmented into Enbrel, Lantus, Neulasta, Avonex, NovoLog, Rebif, Humalog, Aranesp, Epogen, Levemir, Victoza, Betaseron, Neupogen, and Eylea. The mAb segment comprises Humira, Remicade, Rituxan, Avastin, Herceptin and Lucentis. The vaccine segment is further sub-segmented into Prevnar 13, Gardasil, Fluzone, Varivax and Cervarix.


View Report @



Under geographic analysis, the report identifies and analyses the biological drugs market size and provides forecasts for the markets in North America, Europe, Asia and Rest of the World (RoW). Major players operating in the biological drugs market are Pfizer Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, GlaxoSmithKline plc., Bristol-Myers Squibb Company, Merck & Co., Inc., Amgen Inc., Baxter International Inc. and Biogen Idec. These key market players have been profiled based on attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.


Table of Contents


Chapter 1 Preface

1.1 Report Description

1.2 Research methodology

1.2.1 Sources Secondary Research Primary Research Assumptions


Chapter 2 Executive Summary


Chapter 3 Global Biological Drugs Market – Industry Analysis

3.1 Introduction

3.2 Market Drivers

3.2.1 Increasing prevalence of chronic diseases enhance the market growth

3.2.2 Globally geriatric population increases the demand of biological drugs

3.2.3 Various government associations are promoting usage of biological drugs

3.3 Market Opportunities

3.3.1 Advancement in biomedical science promises to boost the development of new biological products

3.4 Restraints

3.4.1 High cost of biological drugs impedes market growth

3.4.2 Patent expiration of various blockbuster biological drugs

3.4.3 Risk of adverse effects associated with biological injectable medicines


Chapter 4 Market Trends

4.1.1 Increasing use of anti-Vascular Endothelial Growth Factor (VEGF) therapy is gaining popularity in biopharmaceutical industry

4.1.2 Genetically Modified Organisms (GMOs) are gaining importance in biological drugs market


Chapter 5 Porter’s Five Forces Analysis

5.1.1 Bargaining power of suppliers

5.1.2 Bargaining power of buyers

5.1.3 Threat of new entrants

5.1.4 Threat of substitutes

5.1.5 Degree of competition


Chapter 6 Global Market Size and Forecast


Chapter 7 Segment Analysis, by Therapeutic Protein

7.1 Enbrel

7.2 Lantus

7.3 Neulasta

7.4 Avonex

7.5 NovoLog

7.6 Rebif

7.7 Humalog

7.8 Aranesp

7.9 Epogen

7.10 Levemir

7.11 Victoza

7.12 Betaseron

7.13 Neupogen

7.14 Eylea


Chapter 8 Segment Analysis, by mAb

8.1 Humira

8.2 Remicade

8.3 Rituxan

8.4 Avastin

8.5 Herceptin

8.6 Lucentis


About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.



Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

1 blogger(s) are following this post, but not you. Follow?
No comments yet.
Post a Comment:

Related Posts: